Advertisement

Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies

      Abstract

      Purpose

      To compare the effect of delayed and early treatment strategies on disease outcome in patients with rheumatoid arthritis.

      Subjects and methods

      Between 1993 and 1995, 109 patients diagnosed with probable or definite rheumatoid arthritis of recent onset were initially treated with analgesics; if they had persistent active disease, they were treated subsequently with the disease-modifying drugs chloroquine or salazopyrine (delayed treatment). Between 1996 and 1998, similar patients (n = 97) were promptly treated with either chloroquine or salazopyrine (early treatment).

      Results

      The median lag to the initiation of disease-modifying treatment was 15 days in the early treatment group and 123 days in the delayed treatment group. There was less radiologic joint damage after 2 years in the early treatment group (median Sharp score, 3.5; 95% confidence interval [CI]: 1 to 7) compared with the delayed treatment group (median Sharp score, 10; 95% CI: 5 to 15; P <0.05). The median area under the curve of the 2-year disease activity score was lower in the early treatment group (64 units; 95% CI: 59 to 69 units) compared with the delayed treatment group (73 units; 95% CI: 69 to 77 units; P = 0.002).

      Conclusion

      In this nonrandomized comparison, early introduction of disease-modifying antirheumatic drugs was associated with a better disease outcome after 2 years.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Machold K.P
        • Eberl G
        • Leeb B.F
        • et al.
        Early arthritis therapy.
        J Rheumatol. 1998; 53: S13-S19
        • van Zeben D
        • Hazes J.M
        • Zwinderman A.H
        • et al.
        The severity of rheumatoid arthritis.
        J Rheumatol. 1994; 21: 1620-1625
        • Emery P
        The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid disease.
        Br J Rheumatol. 1994; 33: 765-768
        • Bensen W.G
        • Bensen W
        • Adachi J.D
        Back to the future.
        J Rheumatol. 1997; 24: 1023-1027
        • Boers M
        • Verhoeven A.C
        • Markusse H.M
        • et al.
        Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
        Lancet. 1997; 350: 309-318
        • Stenger A.A
        • van Leeuwen M.A
        • Houtman P.M
        • et al.
        Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression.
        Br J Rheumatol. 1998; 37: 1157-1163
        • Borg G
        • Allander E
        • Lund B
        • et al.
        Auranofin improves outcome in early rheumatoid arthritis.
        J Rheumatol. 1988; 15: 1747-1754
        • van der Heijde D.M
        • Jacobs J.W
        • Bijlsma J.W
        • et al.
        The effectiveness of early treatment with “second-line” antirheumatic drugs.
        Ann Intern Med. 1996; 124: 699-707
        • Arnett F.C
        • Edworthy S.M
        • Bloch D.A
        • et al.
        The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.
        Arthritis Rheum. 1988; 31: 315-324
        • Ropes M.W
        • Benett G.A
        • Cobbs S
        • et al.
        1958 Revision of diagnostic criteria for rheumatoid arthritis.
        Arthritis Rheum. 1959; 2: 16-20
        • van der Horst-Bruinsma I.E
        • Speyer I
        • Visser H
        • et al.
        Diagnosis and course of early-onset arthritis.
        Br J Rheumatol. 1998; 37: 1084-1088
        • van der Heijde D.M
        • van Riel P.L
        • Nuver-Zwart I.H
        • et al.
        Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.
        Lancet. 1989; 1: 1036-1038
        • van der Heijde D
        Plain x-rays in rheumatoid arthritis.
        Baillieres Clin Rheumatol. 1996; 10: 435-453
        • Fries J.F
        • Spitz P
        • Kraines R.G
        • Holman H.R
        Measurement of patient outcome in arthritis.
        Arthritis Rheum. 1980; 23: 137-145
        • Siegert C.E
        • Vleming L.J
        • Vandenbroucke J.P
        • Cats A
        Measurement of disability in Dutch rheumatoid arthritis patients.
        Clin Rheumatol. 1984; 3: 305-309
        • van der Heijde D.M
        • van ’t Hof M.A
        • van Riel P.L
        • et al.
        Judging disease activity in clinical practice in rheumatoid arthritis.
        Ann Rheum Dis. 1990; 49: 916-920
        • Matthews J.N
        • Altman D.G
        • Campbell M.J
        • Royston P
        Analysis of serial measurements in medical research.
        BMJ. 1990; 300: 230-235
        • Drossaers-Bakker K.W
        • de Buck M
        • van Zeben D
        • et al.
        Long-term course, and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time.
        Arthritis Rheum. 1999; 42: 1854-1860
        • Chan K.W
        • Felson D.T
        • Yood R.A
        • Walker A.M
        The lag time between onset of symptoms and diagnosis of rheumatoid arthritis.
        Arthritis Rheum. 1994; 37: 814-820
        • van Zeben D
        • Hazes J.M
        • Zwinderman A.H
        • et al.
        Factors predicting outcome of rheumatoid arthritis.
        J Rheumatol. 1993; 20: 1288-1296